Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Makishima

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Leukemia|March 15, 2013
Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignanciesS N Khan, A M Jankowska, R Mahfouz, et al.
Leukemia|May 31, 2017
Genomic determinants of chronic myelomonocytic leukemiaB J Patel, B Przychodzen, S Thota, et al.
Leukemia|April 4, 2015
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsR J Molenaar, S Thota, Y Nagata, et al.
Leukemia|August 2, 2016
Somatic PHF6 mutations in 1760 cases with various myeloid neoplasmsT Mori, Y Nagata, H Makishima, et al.
Leukemia|November 4, 2017
A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasiaH Sakai, N Hosono, H Nakazawa, et al.
Leukemia|February 6, 2016
GFI1 as a novel prognostic and therapeutic factor for AML/MDSJ M Hönes, L Botezatu, A Helness, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Leukemia|March 15, 2013
Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignanciesS N Khan, A M Jankowska, R Mahfouz, et al.
Leukemia|May 31, 2017
Genomic determinants of chronic myelomonocytic leukemiaB J Patel, B Przychodzen, S Thota, et al.
Leukemia|April 4, 2015
Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasmsR J Molenaar, S Thota, Y Nagata, et al.
Leukemia|August 2, 2016
Somatic PHF6 mutations in 1760 cases with various myeloid neoplasmsT Mori, Y Nagata, H Makishima, et al.
Leukemia|November 4, 2017
A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasiaH Sakai, N Hosono, H Nakazawa, et al.
Leukemia|February 6, 2016
GFI1 as a novel prognostic and therapeutic factor for AML/MDSJ M Hönes, L Botezatu, A Helness, et al.
Pageof 3